Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Poxel raises funds to advance diabetic drug development
Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the Gliminsand, and is being developed through phase II trials as a monotherapy and as an add-on therapy
Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the Gliminsand, and is being developed through phase II trials as a monotherapy and as an add-on therapy
Abacavir, the generic version of ViiV Healthcare Company’s Ziagen Tablets 300mg, is used to treat HIV infected adults and children as a part of antiretroviral (ARV) combination therapy.
Mylan has commenced shipping the generic medication that is indicated only to treat uncomplicated Plasmodium falciparum malaria. The antimalarial medication works by inhibiting nucleic acid synthesis, protein synthesis
Triveni manufactures and produces plastic containers and closures for the pharma industry, for which it has received the American FDA’s approval. Gerresheimer CFO Hans-Jurgen Wiecha said the purchase
The bioreactor is expected to allow BrainStorm to optimize its NurOwn production process by using a single clean room for multiple patients, reducing costs and time. As part
The testosterone assay is expected to help physicians to accurately measure the wide range of testosterone levels seen in men and women, according to the company. Abbott endocrinology
Under the agreement, Janssen has received an exclusive global license to a series of small molecule drug candidates as well as exclusive rights to further develop the compounds
According to the deal, ProMining will use its CavitIIRx platform in the discovery programme and will receive research based funding. The technology aids in discovering small molecules interfering
Under the agreement, Philip Chapper will fulfil the orders of Bunzl’s disposable healthcare consumables in Malaysia, Malta, US, and Hong Kong. Philip Chapper & Company managing director Philip
Collaboration will focus on studying phosphatidylinositol-3-kinases (PI3K) inhibitors, which regulate PI3K family of enzymes that plays a vital role in immune cell function. One of the collaboration leads